Sign In
Buy LLY
$1,156.63
+2.36 (+0.204%)
At Close: Jul 15, 2026
Human Recombinant Insulin Market Is Booming Worldwide 2021-2028 | Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Julphar Gulf Pharmaceutical Industries
01:07pm, Thursday, 25'th Nov 2021 OpenPR
Major players are focused on launching novel portfolio of human insulin along with receiving regulatory approvals for their product portfolio of insulin. For instance, Eli Lilly and Company, in August 2014, launched Jardiance (empagliflozin) for an option of treatment for
Rapid-acting Diabetes Market 2021 Size, Growth Analysis Report, Forecast to 2027 | Abbott, Bayer, Eli Lilly, BD, Johnson & Johnson, Merck, Pfizer, AstraZeneca
12:49pm, Thursday, 25'th Nov 2021 OpenPR
Global Rapid-acting Diabetes Market 2021-2027 The latest research study on Global Rapid-acting Diabetes Market offers a detailed overview of the factors influencing the global business scope. Rapid-acting Diabetes Market research report shows the latest market insights, current situation analysis with upcoming
Truist Securities Increases Eli Lilly and (NYSE:LLY) Price Target to $301.00
04:40pm, Wednesday, 24'th Nov 2021 Dakota Financial News
Eli Lilly and (NYSE:LLY) had its price target boosted by investment analysts at Truist Securities from $262.00 to $301.00 in a research report issued on Wednesday, Stock Target Advisor reports. The brokerage presently has a buy rating on the stock. Truist Securities price objective suggests a potential upside of 15.50% from the stocks previous close. []
Glucagon Like Peptide-1 (GLP-1) Agonists Market 2021 Analysis by Top Manufacturers| Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi, Bristol-Myers Squibb, Amylin
05:25am, Wednesday, 24'th Nov 2021 OpenPR
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2027 Glucagon Like Peptide-1 (GLP-1) Agonists Market research performs thorough market analysis and uses a variety of sources to provide key players with wide-ranging knowledge about industry strategies. This analysis
Eli Lilly and Company bags $535M US Army contract for combination therapeutic doses
10:28pm, Tuesday, 23'rd Nov 2021 Seeking Alpha
Five Oceans Advisors Makes New $257,000 Investment in Eli Lilly and Company (NYSE:LLY)
07:42pm, Tuesday, 23'rd Nov 2021 Dakota Financial News
Five Oceans Advisors bought a new position in shares of Eli Lilly and Company (NYSE:LLY) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,111 shares of the companys stock, valued at approximately $257,000. A number of other hedge funds and []
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Grows Holdings in Eli Lilly and Company (NYSE:LLY)
06:54pm, Tuesday, 23'rd Nov 2021 Transcript Daily
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its position in shares of Eli Lilly and Company (NYSE:LLY) by 6.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,817 shares of the companys stock after buying an additional 1,906 shares during the quarter. Eli Lilly []
Injection Pen Market research report gives a thorough idea about the current scenario of the global market, recent developments, product launches, joint ventures, capacity, production value, mergers, and acquisitions based on several market dynamics. It gives key measurements, the status
Hold Moderna here, but buy some more Eli Lilly
12:14am, Tuesday, 23'rd Nov 2021 Bitcoin Ethereum News
The post Hold Moderna here, but buy some more Eli Lilly appeared on BitcoinEthereumNews.com . Ambarella: I think you ought to sell half right here. Honestly, look, theres some luck involved here because the stuff that they do, I think, is a little more commodity-oriented
Cramer''s lightning round: Hold Moderna here, but buy some more Eli Lilly
12:04am, Tuesday, 23'rd Nov 2021 CNBC
"Mad Money" host Jim Cramer rings the lightning round bell, which means he''s giving his answers to callers'' stock questions at rapid speed.
Shares of RNAi Drug Companies Pop After Novo Lays Out $3.3 Billion for Dicerna
10:48pm, Monday, 22'nd Nov 2021 GuruFocus
Arrowhead and Alnylam up by 8% each Related Stocks: NVO , DRNA , LLY , MRK , ALNY , ARWR , NVS , ALXN , RHHBY ,
Family Legacy Inc. Acquires 46 Shares of Eli Lilly and Company (NYSE:LLY)
05:18pm, Monday, 22'nd Nov 2021 Transcript Daily
Family Legacy Inc. grew its holdings in shares of Eli Lilly and Company (NYSE:LLY) by 0.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 11,574 shares of the companys stock after buying an additional 46 shares during the period. Family Legacy Inc.s holdings in Eli []
KMG Fiduciary Partners LLC Has $1.58 Million Stake in Eli Lilly and Company (NYSE:LLY)
05:18pm, Monday, 22'nd Nov 2021 Dakota Financial News
KMG Fiduciary Partners LLC boosted its position in shares of Eli Lilly and Company (NYSE:LLY) by 87.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,829 shares of the companys stock after acquiring an additional 3,193 shares during the []
BFT Financial Group LLC Has $551,000 Stock Holdings in Eli Lilly and Company (NYSE:LLY)
03:36pm, Monday, 22'nd Nov 2021 Dakota Financial News
BFT Financial Group LLC decreased its holdings in Eli Lilly and Company (NYSE:LLY) by 3.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,383 shares of the companys stock after selling 77 shares during the quarter. BFT Financial Group LLCs holdings in []
Tumour Vaccine Market Trend, Size, Share, Demands and Top Companies Pfizer, Merck & Co Inc, Eli Lilly and Company, BioNTech, Roche Holding AG
01:12pm, Monday, 22'nd Nov 2021 OpenPR
Tumour Vaccine Market analysis report puts across the idea of a high-level analysis of major market segments and identification of opportunities. This information not only aids businesses in taking sound and proficient decisions but also helps decide the advertising, promotion,
